MissionIR Articles
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its CEO and Chairman Chris Bunka will present at the 23rd Annual H.C. Wainwright Global Investment Conference. The event…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO to Present Virtually at H.C. Wainwright 23rd Annual Global Investment Conference
Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company focused on advancing psychedelic pharmaceutical therapeutics for various psychiatric and neurological conditions, today announced that on Monday, September 13, 2021, Chief Executive Officer Doug Drysdale…
-
MissionIRNewsBreaks — Save Foods Inc. (NASDAQ: SVFD) Receives Patent for Proprietary Compound from European Office
Save Foods (NASDAQ: SVFD), an agri-food-tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure food safety of fresh fruits and vegetables, announced that the European patent…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Slated for Live Webcast at VirtualInvestorConferences.com
InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“CBN”), will be featured at the upcoming VirtualInvestorConferences.com. InMed president and…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Marks Milestone with Receipt of 2021 Commercial Export Quota of Psychoactive Cannabis Flower from Colombian Government
Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has received its 2021 export quota from the Colombian Technical Quotas Group (“TQG”) of 7,900 kilograms of high-THC cannabis…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Results of Human Clinical Study Showing Effective, Safe BP Reduction
Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced that its human clinical study HYPER-H21-2, which features LEXX’s patented DehydraTECH(TM)-processed cannabidiol (“CBD”), demonstrates up to a 23% decrease in blood pressure when…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Reminds Holders about Warrants Expiration
Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, has issued a reminder. The company alerted holders of its outstanding common share purchase warrants that the warrants are scheduled…
-
MissionIRNewsBreaks – Kaival Brands Innovations Group Inc. (NASDAQ: KAVL) Eyes Launch of New Proprietary CBD Products
Kaival Brands (NASDAQ: KAVL), a company focused on developing products into mature, dominant brands, is looking to launch a new line of proprietary cannabidiol (“CBD”) products. The company intends to follow a similar design path…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Reports on Milestone Achievements Reached by Subsidiary
Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on psychedelic pharmaceutical therapies, has announced that Adelia Therapeutics Inc., its wholly controlled subsidiary, has reached key milestones for Year 1 Q3. The milestones were outlined…
-
MissionIRNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Releases Q2 2021 Financials, Business Highlights
Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, has reported its second quarter 2021 financials. The report includes the news that adjusted sales for the first…
-
MissionIRNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Announces Q1 2022 Results
PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) has announced its interim unaudited condensed consolidated financial results for the three months ended June 30, 2021. All amounts are reported in Canadian dollars unless otherwise specified. Among…
-
MissionIRNewsBreaks – Save Foods Inc. (NASDAQ: SVFD) Announces Appointment of Dariela Farcas as PR & IR Director
Save Foods (NASDAQ: SVFD), an agri-food-tech company focused on developing and selling eco-friendly products specifically designed to extend shelf life and ensure food safety of fresh fruits and vegetables, today announced the appointment of Dariela…
-
MissionIRNewsBreaks – AnPac Bio-Medical Science Co. Ltd.’s (NASDAQ: ANPC) CLIA Laboratory Receives Accreditation from the College of American Pathologists
AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that its Philadelphia, Pennsylvania-based Clinical Laboratory Improvement Amendments (“CLIA”) certified laboratory has received accreditation from the College of…
-
MissionIRNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Announces Transformative Deal to Acquire VIA Motors
Ideanomics (NASDAQ: IDEX), a global company focused on driving the adoption of commercial electric vehicles and associated energy consumption, today announced its entry into an agreement to acquire VIA Motors International Inc. (“VIA”) in an…
-
MissionIRNewsBreaks – TAAT Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) Launches Revamped TryTAAT Site
TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) has announced an updated e-commerce portal: TryTAAT.com. The company noted that it was working to make the website more engaging and fun by revamping the site…
-
MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces Approval of Charter Amendment
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that on Aug. 17, 2021, the stockholders approved an amendment to the company’s certificate…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American CYBN) Files 14th Patent Application, Announces New Board Member
Cybin (NEO: CYBN) (NYSE American CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has filed a nonprovisional patent application in support of its ongoing drug candidate programs. The company noted that it had completed a…
-
MissionIRNewsBreaks – Ideanomics Inc. (NASDAQ: IDEX) Releases Financial Report for Second Quarter 2021
Ideanomics (NASDAQ: IDEX), a global company focused on driving the adoption of commercial electric vehicles and associated energy consumption, has reported its Q2 2021 operating and financial results for the period ended June 30, 2021. Highlights…
-
MissionIRNewsBreaks – Infobird Software Co. Ltd. (NASDAQ: IFBD) Announces New WeChat Call Center Designed to Capture New Demand, Market Share
Infobird (NASDAQ: IFBD), a software-as-a-service (“SaaS”) provider of innovative AI-powered, or artificial intelligence-enabled, customer engagement solutions in China, has unveiled its newest intelligent SaaS product, a WeChat Call Center. This new product marks Infobird’s entry…
-
MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Continued Revenue Growth in Q2 2021, Increases Full-Year Guidance
SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today issued unaudited financial results for the second quarter of 2021. Among recent operational…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Marks Bold Entry Into the Growing Battery Storage Market with 4.99 MW BESS in Ontario
- Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial